Patterns of Care and Data Quality in a National Registry of Black and White Patients with Merkel Cell Carcinoma

被引:2
|
作者
Rattani, Abbas [1 ]
Gaskins, Jeremy [2 ]
McKenzie, Grant [3 ]
Scharf, Virginia Kate [4 ]
Broman, Kristy [5 ]
Pisu, Maria [6 ]
Holder, Ashley [5 ]
Dunlap, Neal [3 ]
Schwartz, David [7 ]
Yusuf, Mehran B. [8 ]
机构
[1] Tufts Univ, Dept Radiat Oncol, Med Ctr, Boston, MA 02111 USA
[2] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40202 USA
[3] Univ Louisville, Brown Canc Ctr, Dept Radiat Oncol, Sch Med, Louisville, KY 40202 USA
[4] Univ Louisville, Sch Med, Louisville, KY 40202 USA
[5] Univ Alabama Birmingham, Dept Surg, Div Surg Oncol, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[7] Univ Tennessee, Dept Radiat Oncol, Hlth Sci Ctr, Memphis, TN 38163 USA
[8] Univ Alabama Birmingham, Dept Radiat Oncol, ONeal Comprehens Canc Ctr, Sch Med, Birmingham, AL 35294 USA
关键词
Merkel Cell Carcinoma; race; epidemiology; SURVIVAL; EPIDEMIOLOGY; CANCER; RACE;
D O I
10.3390/cancers14205059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Merkel Cell Carcinoma is a rare skin cancer most commonly affecting White patients. Less is known for Black patients. We aimed to report presentation, treatment, and quality of registry data by race with a secondary endpoint of overall survival. Findings from this work aim to impact patient and provider awareness to further equitable access to optimal cancer care across the spectrum from diagnosis and treatment to post-therapy surveillance for patients with Merkel Cell Carcinoma. Merkel Cell Carcinoma (MCC) is a rare cancer most commonly affecting White patients; less is known for Black patients. We aim to report presentation, treatment, and quality of registry data by race with a secondary endpoint of overall survival. We conducted a retrospective cohort analysis between 2006-2017 via the National Cancer Database of Black and White MCC patients with and without known staging information. Multivariable logistic, proportional odds logistic, and baseline category logistic regression models were used for our primary endpoint. Multivariable Cox regression was used to interrogate overall survival. Multiple imputation was used to mitigate missing data bias. 34,503 patients with MCC were included (2566 Black patients). Black patients were younger (median age 52 vs. 72, p < 0.0001), had higher rates of immunosuppression (28% vs. 14%, p = 0.0062), and were more likely to be diagnosed at a higher stage (proportional OR = 1.41, 95% CI 1.25-1.59). No differences were noted by race across receipt of definitive resection (DR), though Black patients did have longer time from diagnosis to DR. Black patients were less likely to receive adjuvant radiation. Black patients were more likely to have missing cancer stage (OR = 1.69, CI 1.52-1.88). Black patients had decreased adjusted risk of mortality (HR 0.73, 0.65-0.81). Given the importance of registry analyses for rare cancers, efforts are needed to ensure complete data coding. Paramount to ensuring equitable access to optimal care for all is the recognition that MCC can occur in Black patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Merkel Cell Carcinoma - Epidemiology Data from the Czech National Cancer Registry
    Bajciova, V.
    Barkmanova, J.
    Zvolsky, M.
    Sedlackova, E.
    NEUROENDOCRINOLOGY, 2016, 103 : 14 - 14
  • [2] Epidemiology and primary site of Merkel cell carcinoma among black patients: results from a national cancer registry
    Borda, Luis J.
    Sobanko, Joseph F.
    Higgins II, H. William
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (05)
  • [3] High cardiovascular mortality risk among older merkel cell carcinoma patients
    Huang, Jia-nan
    Yu, Hai
    Xia, Xichun
    Ming, Wai-kit
    Wu, Shuai
    Cheng, Leong Nga
    Ying, Lee. ALice Yu
    Zhang, Jinrong
    Jiang, Yuzhen
    Chen, Wenhui
    Zhao, Qiqi
    Lyu, Jun
    Deng, Liehua
    BMC GERIATRICS, 2024, 24 (01)
  • [4] Merkel cell carcinoma in non-White Hispanic patients: Demographics and primary site
    Borda, Luis J.
    Pugliano-Mauro, Melissa A.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (09) : 1280 - 1281
  • [5] Merkel Cell Polyomavirus Antibody in Tumor and Plasma Specimens in Patients with Merkel Cell Carcinoma
    Schmocker, Ryan K.
    Nodit, Laurentia
    Ward, Andrew J.
    Lewis, James M.
    McLoughlin, James M.
    Enomoto, Laura M.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (01) : 464 - 473
  • [6] Survival among Black and White patients with renal cell carcinoma in an equal-access health care system
    Lin, Jie
    Zahm, Shelia H.
    Shriver, Craig D.
    Purdue, Mark
    McGlynn, Katherine A.
    Zhu, Kangmin
    CANCER CAUSES & CONTROL, 2015, 26 (07) : 1019 - 1026
  • [7] Prognostic factors in the primary care of patients with Merkel cell carcinoma: A monocentric cohort study of 108 patients from a tertiary referral centre
    Placke, Jan-Malte
    Zahn, Maximilian
    Zillikens, Hannah
    Krefting, Frederik
    Lodde, Georg C.
    Zimmer, Lisa
    Livingstone, Elisabeth
    Hadaschik, Eva
    Sucker, Antje
    Roesch, Alexander
    Tasdogan, Alpaslan
    Srinivas, Nalini K.
    Schadendorf, Dirk
    Becker, Juergen C.
    Ugurel, Selma
    JEADV CLINICAL PRACTICE, 2023, 2 (04): : 810 - 818
  • [8] Care of Merkel cell carcinoma and role of the radiotherapy
    Rehailia-Blanchard, Amel
    Pigne, Gregoire
    Guy, Jean-Baptiste
    Vallard, Alexis
    Hamrouni, Anis El Meddeb
    Rancoule, Chloe
    Magne, Nicolas
    BULLETIN DU CANCER, 2017, 104 (01) : 101 - 108
  • [9] Patterns of Metastasis in Merkel Cell Carcinoma
    Song, Yun
    Azari, Feredun S.
    Tang, Rebecca
    Shannon, Adrienne B.
    Miura, John T.
    Fraker, Douglas L.
    Karakousis, Giorgos C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (01) : 519 - 529
  • [10] Differences in Survival between Black and White Patients with Head and Neck Squamous Cell Carcinoma: Comparison of Data from the DOD Central Cancer Registry and SEER
    Lin, Jie
    Orestes, Michael I.
    Shriver, Craig D.
    Zhu, Kangmin
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (03) : 426 - 434